Long-term GH replacement therapy is indicated for children with growth failure due to GH deficiency (GHD). We evaluated the feasibility of administering a long-acting GH preparation [Nutropin Depot (somatropin, rDNA origin) for injectable suspension] to p
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.All Scholarly Works
Document TypeArticle, Peer-reviewed
Citation InformationJ Clin Endocrinol Metab 2004 Jul;89(7):3234-40.